Skip to main content
Erasca, Inc. logo

Erasca, Inc. — Investor Relations & Filings

Ticker · ERAS ISIN · US29479A1088 US Manufacturing
Filings indexed 306 across all filing types
Latest filing 2023-05-15 Interim / Quarterly Rep…
Country US United States of America
Listing US ERAS

About Erasca, Inc.

https://www.erasca.com/

Erasca, Inc. is a clinical-stage precision oncology company with the mission to erase cancer. The company focuses on discovering, developing, and commercializing therapies for patients with cancers driven by mutations in the RAS/MAPK pathway, one of the most frequently altered signaling cascades in human tumors. Erasca is advancing a robust, modality-agnostic portfolio of therapeutic programs purposefully built to comprehensively target and shut down this pathway. This approach aims to address significant unmet medical needs and provide transformative treatments for a wide range of cancers.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q1 2023
2023-05-15 English
8-K
Regulatory Filings
2023-05-15 English
ARS
Annual Report
2023-04-28 English
DEFA14A
Regulatory Filings
2023-04-28 English
DEF 14A
Proxy Solicitation & Information Statement
2023-04-28 English
8-K
Regulatory Filings
2023-04-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.